Naoto Yoshinaga, Keiji Numata. ACS Biomater Sci Eng 2022
Times Cited: 1
Times Cited: 1
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Divya Pathania, Melissa Millard, Nouri Neamati. Adv Drug Deliv Rev 2009
Divya Pathania, Melissa Millard, Nouri Neamati. Adv Drug Deliv Rev 2009
100
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100
Organelle-targeted photothermal agents for cancer therapy.
Eunbin Hwang, Hyo Sung Jung. Chem Commun (Camb) 2021
Eunbin Hwang, Hyo Sung Jung. Chem Commun (Camb) 2021
100
Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
Jacek Zielonka, Joy Joseph, Adam Sikora, Micael Hardy, Olivier Ouari, Jeannette Vasquez-Vivar, Gang Cheng, Marcos Lopez, Balaraman Kalyanaraman. Chem Rev 2017
Jacek Zielonka, Joy Joseph, Adam Sikora, Micael Hardy, Olivier Ouari, Jeannette Vasquez-Vivar, Gang Cheng, Marcos Lopez, Balaraman Kalyanaraman. Chem Rev 2017
100
Multifunctional nanoparticles for multimodal imaging and theragnosis.
Dong-Eun Lee, Heebeom Koo, In-Cheol Sun, Ju Hee Ryu, Kwangmeyung Kim, Ick Chan Kwon. Chem Soc Rev 2012
Dong-Eun Lee, Heebeom Koo, In-Cheol Sun, Ju Hee Ryu, Kwangmeyung Kim, Ick Chan Kwon. Chem Soc Rev 2012
100
Boosting Cancer Therapy with Organelle-Targeted Nanomaterials.
Peng Gao, Wei Pan, Na Li, Bo Tang. ACS Appl Mater Interfaces 2019
Peng Gao, Wei Pan, Na Li, Bo Tang. ACS Appl Mater Interfaces 2019
100
Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.
Xianglei Fu, Yanbin Shi, Tongtong Qi, Shengnan Qiu, Yi Huang, Xiaogang Zhao, Qifeng Sun, Guimei Lin. Signal Transduct Target Ther 2020
Xianglei Fu, Yanbin Shi, Tongtong Qi, Shengnan Qiu, Yi Huang, Xiaogang Zhao, Qifeng Sun, Guimei Lin. Signal Transduct Target Ther 2020
100
Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione.
K Barnouin, I Leier, G Jedlitschky, A Pourtier-Manzanedo, J König, W D Lehmann, D Keppler. Br J Cancer 1998
K Barnouin, I Leier, G Jedlitschky, A Pourtier-Manzanedo, J König, W D Lehmann, D Keppler. Br J Cancer 1998
100
Hetero-Trifunctional Malonate-Based Nanotheranostic System for Targeted Breast Cancer Therapy.
Tapan Kumar Dash, Diptendu Patra, Parvathy Venu, Biswajit Das, Rangeet Bhattacharyya, Raja Shunmugam. ACS Appl Bio Mater 2021
Tapan Kumar Dash, Diptendu Patra, Parvathy Venu, Biswajit Das, Rangeet Bhattacharyya, Raja Shunmugam. ACS Appl Bio Mater 2021
100
Mitochondrially targeted anti-cancer agents.
Lucia Biasutto, Lan-Feng Dong, Mario Zoratti, Jiri Neuzil. Mitochondrion 2010
Lucia Biasutto, Lan-Feng Dong, Mario Zoratti, Jiri Neuzil. Mitochondrion 2010
100
Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells.
Sonali B Fonseca, Mark P Pereira, Rida Mourtada, Marcela Gronda, Kristin L Horton, Rose Hurren, Mark D Minden, Aaron D Schimmer, Shana O Kelley. Chem Biol 2011
Sonali B Fonseca, Mark P Pereira, Rida Mourtada, Marcela Gronda, Kristin L Horton, Rose Hurren, Mark D Minden, Aaron D Schimmer, Shana O Kelley. Chem Biol 2011
100
Drug delivery to mitochondria: the key to mitochondrial medicine.
M P Murphy, R A Smith. Adv Drug Deliv Rev 2000
M P Murphy, R A Smith. Adv Drug Deliv Rev 2000
100
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
Robert J McDonald, Jennifer S McDonald, David F Kallmes, Mark E Jentoft, David L Murray, Kent R Thielen, Eric E Williamson, Laurence J Eckel. Radiology 2015
Robert J McDonald, Jennifer S McDonald, David F Kallmes, Mark E Jentoft, David L Murray, Kent R Thielen, Eric E Williamson, Laurence J Eckel. Radiology 2015
100
Fe(deferasirox)2: An Iron(III)-Based Magnetic Resonance Imaging T1 Contrast Agent Endowed with Remarkable Molecular and Functional Characteristics.
Lorenzo Palagi, Enza Di Gregorio, Diana Costanzo, Rachele Stefania, Camilla Cavallotti, Martina Capozza, Silvio Aime, Eliana Gianolio. J Am Chem Soc 2021
Lorenzo Palagi, Enza Di Gregorio, Diana Costanzo, Rachele Stefania, Camilla Cavallotti, Martina Capozza, Silvio Aime, Eliana Gianolio. J Am Chem Soc 2021
100
Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
Philipp Boehm-Sturm, Akvile Haeckel, Ralf Hauptmann, Susanne Mueller, Christiane K Kuhl, Eyk A Schellenberger. Radiology 2018
Philipp Boehm-Sturm, Akvile Haeckel, Ralf Hauptmann, Susanne Mueller, Christiane K Kuhl, Eyk A Schellenberger. Radiology 2018
100
Triphenylphosphonium Decorated Liposomes and Dendritic Polymers: Prospective Second Generation Drug Delivery Systems for Targeting Mitochondria.
Constantinos M Paleos, Dimitris Tsiourvas, Zili Sideratou. Mol Pharm 2016
Constantinos M Paleos, Dimitris Tsiourvas, Zili Sideratou. Mol Pharm 2016
100
100
Cancer nanomedicine: progress, challenges and opportunities.
Jinjun Shi, Philip W Kantoff, Richard Wooster, Omid C Farokhzad. Nat Rev Cancer 2017
Jinjun Shi, Philip W Kantoff, Richard Wooster, Omid C Farokhzad. Nat Rev Cancer 2017
100
Iron(III) Coordinated Polymeric Nanomaterial: A Next-Generation Theranostic Agent for High-Resolution T1-Weighted Magnetic Resonance Imaging and Anticancer Drug Delivery.
Diptendu Patra, Saikat Mukherjee, Ipsita Chakraborty, Tapan K Dash, Shantibhusan Senapati, Rangeet Bhattacharyya, Raja Shunmugam. ACS Biomater Sci Eng 2018
Diptendu Patra, Saikat Mukherjee, Ipsita Chakraborty, Tapan K Dash, Shantibhusan Senapati, Rangeet Bhattacharyya, Raja Shunmugam. ACS Biomater Sci Eng 2018
100
Residual or retained gadolinium: practical implications for radiologists and our patients.
Emanuel Kanal, Michael F Tweedle. Radiology 2015
Emanuel Kanal, Michael F Tweedle. Radiology 2015
100
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
100
Targeted Mitochondrial Fluorescence Imaging-Guided Tumor Antimetabolic Therapy with the Imprinted Polymer Nanomedicine Capable of Specifically Recognizing Dihydrofolate Reductase.
Ya-Ting Qin, Yao-Jia Ma, Yu-Sheng Feng, Xi-Wen He, Wen-You Li, Yu-Kui Zhang. ACS Appl Mater Interfaces 2021
Ya-Ting Qin, Yao-Jia Ma, Yu-Sheng Feng, Xi-Wen He, Wen-You Li, Yu-Kui Zhang. ACS Appl Mater Interfaces 2021
100
Mitochondrial dysfunction in cancer.
Josephine S Modica-Napolitano, Keshav K Singh. Mitochondrion 2004
Josephine S Modica-Napolitano, Keshav K Singh. Mitochondrion 2004
100
Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze, Sten Orrenius, Boris Zhivotovsky. Trends Cell Biol 2008
Vladimir Gogvadze, Sten Orrenius, Boris Zhivotovsky. Trends Cell Biol 2008
100
Tetraphenylporphine-Modified Polymeric Nanoparticles Containing NIR Photosensitizer for Mitochondria-Targeting and Imaging-Guided Photodynamic Therapy.
Pan Yuan, Zheng Ruan, Lifeng Yan. ACS Biomater Sci Eng 2020
Pan Yuan, Zheng Ruan, Lifeng Yan. ACS Biomater Sci Eng 2020
100
Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
Javier Perez-Rodriguez, Shenghan Lai, Benjamin D Ehst, Derek M Fine, David A Bluemke. Radiology 2009
Javier Perez-Rodriguez, Shenghan Lai, Benjamin D Ehst, Derek M Fine, David A Bluemke. Radiology 2009
100
Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition.
Furong Cheng, Qingqing Pan, Wenxia Gao, Yuji Pu, Kui Luo, Bin He. ACS Appl Mater Interfaces 2021
Furong Cheng, Qingqing Pan, Wenxia Gao, Yuji Pu, Kui Luo, Bin He. ACS Appl Mater Interfaces 2021
100
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
100
MRI for breast cancer screening, diagnosis, and treatment.
Monica Morrow, Janet Waters, Elizabeth Morris. Lancet 2011
Monica Morrow, Janet Waters, Elizabeth Morris. Lancet 2011
100
Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applications.
Fuyao Liu, Xiuxia He, Hongda Chen, Junping Zhang, Huimao Zhang, Zhenxin Wang. Nat Commun 2015
Fuyao Liu, Xiuxia He, Hongda Chen, Junping Zhang, Huimao Zhang, Zhenxin Wang. Nat Commun 2015
100
Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu.
J K Horton, G Roy, J T Piper, B Van Houten, Y C Awasthi, S Mitra, M A Alaoui-Jamali, I Boldogh, S S Singhal. Biochem Pharmacol 1999
J K Horton, G Roy, J T Piper, B Van Houten, Y C Awasthi, S Mitra, M A Alaoui-Jamali, I Boldogh, S S Singhal. Biochem Pharmacol 1999
100
Combinatorial drug therapy for cancer in the post-genomic era.
Bissan Al-Lazikani, Udai Banerji, Paul Workman. Nat Biotechnol 2012
Bissan Al-Lazikani, Udai Banerji, Paul Workman. Nat Biotechnol 2012
100
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.
Jessica Wahsner, Eric M Gale, Aurora Rodríguez-Rodríguez, Peter Caravan. Chem Rev 2019
Jessica Wahsner, Eric M Gale, Aurora Rodríguez-Rodríguez, Peter Caravan. Chem Rev 2019
100
Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy.
Xiaowei Wang, Yuhan Qiu, Mengyan Wang, Conghui Zhang, Tianshu Zhang, Huimin Zhou, Wenxia Zhao, Wuli Zhao, Guimin Xia, Rongguang Shao. Int J Nanomedicine 2020
Xiaowei Wang, Yuhan Qiu, Mengyan Wang, Conghui Zhang, Tianshu Zhang, Huimin Zhou, Wenxia Zhao, Wuli Zhao, Guimin Xia, Rongguang Shao. Int J Nanomedicine 2020
100
Structural modifications of mitochondria-targeted chlorambucil alter cell death mechanism but preserve MDR evasion.
Sae Rin Jean, Mark P Pereira, Shana O Kelley. Mol Pharm 2014
Sae Rin Jean, Mark P Pereira, Shana O Kelley. Mol Pharm 2014
100
Defining the conditions for the development of the emerging class of FeIII-based MRI contrast agents.
Zsolt Baranyai, Fabio Carniato, Alessandro Nucera, Dávid Horváth, Lorenzo Tei, Carlos Platas-Iglesias, Mauro Botta. Chem Sci 2021
Zsolt Baranyai, Fabio Carniato, Alessandro Nucera, Dávid Horváth, Lorenzo Tei, Carlos Platas-Iglesias, Mauro Botta. Chem Sci 2021
100
A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
Melissa Millard, John D Gallagher, Bogdan Z Olenyuk, Nouri Neamati. J Med Chem 2013
Melissa Millard, John D Gallagher, Bogdan Z Olenyuk, Nouri Neamati. J Med Chem 2013
100
The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants.
Lorien J Parker, Sarah Ciccone, Louis C Italiano, Alessandra Primavera, Aaron J Oakley, Craig J Morton, Nancy C Hancock, Mario Lo Bello, Michael W Parker. J Mol Biol 2008
Lorien J Parker, Sarah Ciccone, Louis C Italiano, Alessandra Primavera, Aaron J Oakley, Craig J Morton, Nancy C Hancock, Mario Lo Bello, Michael W Parker. J Mol Biol 2008
100
100
Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update.
N Jalandhara, R Arora, V Batuman. Clin Pharmacol Ther 2011
N Jalandhara, R Arora, V Batuman. Clin Pharmacol Ther 2011
100
Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.
Gantumur Battogtokh, Yeon Su Choi, Dong Seop Kang, Sang Jun Park, Min Suk Shim, Kang Moo Huh, Yong-Yeon Cho, Joo Young Lee, Hye Suk Lee, Han Chang Kang. Acta Pharm Sin B 2018
Gantumur Battogtokh, Yeon Su Choi, Dong Seop Kang, Sang Jun Park, Min Suk Shim, Kang Moo Huh, Yong-Yeon Cho, Joo Young Lee, Hye Suk Lee, Han Chang Kang. Acta Pharm Sin B 2018
100
The role of glutathione-S-transferase in anti-cancer drug resistance.
Danyelle M Townsend, Kenneth D Tew. Oncogene 2003
Danyelle M Townsend, Kenneth D Tew. Oncogene 2003
100
Targeted combinational therapy inducing mitochondrial dysfunction.
Weon Sup Shin, Soon Ki Park, Peter Verwilst, Seyoung Koo, Joung Hae Lee, Sung-Gil Chi, Jong Seung Kim. Chem Commun (Camb) 2017
Weon Sup Shin, Soon Ki Park, Peter Verwilst, Seyoung Koo, Joung Hae Lee, Sung-Gil Chi, Jong Seung Kim. Chem Commun (Camb) 2017
100
DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells.
J A Hartley, J P Bingham, R L Souhami. Nucleic Acids Res 1992
J A Hartley, J P Bingham, R L Souhami. Nucleic Acids Res 1992
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.